<div id="readability-page-1" class="page"><div> Novartis to Buy Biotech Excellergy for Up to $2 Billion Novartis agreed to buy Excellergy, bulking up its immunology portfolio with a biotech company that specializes in treatments for food allergy and other diseases. ---- China's Moonshot AI Seeks Listing in Hong Kong Under Heightened Scrutiny Moonshot AI, one of China's most promising artificial-intelligence startups, is considering changing its corporate structure to pave the way for an initial public offering in Hong Kong. ---- Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman The two companies are discussing a deal that is mostly stock and could be weeks away. ---- Jeep Cherokee Production Halted Over Supplier Dispute In a lawsuit, Stellantis said a payment dispute with a supplier has shut down a Mexican factory since March 14. ---- Anthropic Wins Injunction in Court Battle With Trump Administration A federal judge said the government's 'measures appear designed to punish Anthropic' in a standoff over military use of A.I. ---- The SpaceX IPO Will Be Just as Unconventional as Musk Himself From the investor meetings to how shares are doled out, Elon Musk is navigating his own path. ---- Orbital Data-Center Startup Aetherflux Raising New Financing at $2 Billion Valuation Aetherflux, led by Robinhood co-founder Baiju Bhatt, seeks to launch solar-powered satellites for AI computing. ---- An AI Upheaval Is Coming for Media. This Journalist Is Already All In. AI-assisted stories accounted for nearly 20% of Fortune's web traffic in the second half of 2025. Most are written by Nick Lichtenberg. ---- Netflix Raises Prices. Streaming Is Going to Keep Getting More Expensive. Netflix updated its plans page on Thursday. ---- FTC Issues Warnings to Payment Processors Against 'Debanking' Mastercard, Visa, PayPal and Stripe received letters warning them against denying customers access to financial services due to their political or religious views. ---- Why Tesla isn't getting a boost from high gas prices Higher EV prices and borrowing costs may be turning prospective buyers away. ---- GlobalFoundries Sues Tower Semiconductor for Patent Infringement The lawsuits allege that Tower infringed on 11 GlobalFoundries' patents in the U.S. ---- H&amp;M Earnings Rise as Cost Control Offsets Subdued Sales The fast-fashion retailer said sales picked up in February due to well-received spring collections, with the trend continuing into March. ---- Designer Brands Comparable Sales Fall Designer Brands reported lower comparable sales for the fiscal fourth quarter, dragged down by a decline in its direct-to-consumer channel. <pre></pre> (END) Dow Jones Newswires March 27, 2026 03:15 ET (07:15 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

諾華制藥

伊克力西斯

LYEL

諾華計劃以高達 20 億美元收購 Excellergy，以增強其免疫學產品組合。與此同時，中國的 Moonshot AI 正在探索企業重組，以便在香港進行潛在的首次公開募股（IPO）。保樂力加正在與 Brown-Forman 進行合併談判，而斯特蘭蒂斯因供應商爭議已暫停 Jeep Cherokee 的生產。Anthropic 贏得了一項針對特朗普政府關於軍事人工智能使用的法院禁令。由 Robinhood 聯合創始人領導的初創公司 Aetherflux 正在以 20 億美元的估值籌集資金。奈飛已提高其價格，顯示出流媒體成本上升的趨勢

Dow Jones Top Company Headlines at 3 AM ET: Novartis to Buy Biotech Excellergy for Up to $2 Billion | China's ...

- 諾華同意以高達 20 億美元收購生物技術公司 Excellergy。  
- 中國的 Moonshot AI 考慮變更公司結構，以便在香港上市。  
- 斯特蘭提斯因與供應商的爭端，自 3 月 14 日起停產 Jeep Cherokee。

MorningStar

Lyell Immunopharma

奈飛

Novartis AG

2 倍做多納斯達克生物技術 ETF - ProShares

標普全球醫療股指數 ETF - iShares

醫藥突破 ETF - ALPS

標普生物技術 3 倍做多 - Direxion

基因改革 ETF - ARK

美國醫藥設備 ETF - iShares

醫療業 ETF - SPDR

Invesco Nasdaq Biotechnology ETF

標普生物技術 ETF - SPDR

納斯達克生物科技指數 ETF - iShares Nasdaq

標普健康醫療設備 ETF - SPDR

2 倍做多 NFLX ETF - T-Rex

美國制藥 ETF - iShares

紐交所高增長板生物技術指數 ETF - First Trust

醫療業 ETF - Vanguard

道瓊斯公司頭條新聞在凌晨 3 點：諾華製藥計劃以最高 20 億美元收購生物技術公司 Excellergy | 中國的